Dragons Den Entrepreneur James Caan Invests in Euromedica Life Sciences Search Consultancy.
Dragons’ Den Entrepreneur James Caan Invests in Euromedica Life Sciences Search Consultancy.
Euromedica, the Global Search Consultancy in Life Sciences, has announced a new partnership with Hamilton Bradshaw (HB), James Caan’s Private Equity Company. This marks a first for HB by investing in the ever expanding Life Sciences industry. With this partnership HB reinforces its focus on investing in strong leadership teams in the Executive Search industry.
The Euromedica Management Buyout (MBO) and HB join forces with Ian Lloyd, founder of Oxygen Executive Search who will act as the Company’s new Chairman. Ian, former Managing Director of Odgers has over 20 years’ experience in Executive Search including Life Sciences. The new management team will be led by Thomas Schleimer as Managing Partner, along with Tom Bradley, Michael Ade and Frank Lippens. The four founding partners have more than 100 years of combined experience from both industry and Executive Search in the Life Sciences and Health Care sectors.
Euromedica’s structure, value proposition and capabilities will remain as before and the personnel team will transfer and continue to function as normal. HB will work with the
management team to attract new talent, whilst developing the Euromedica brand. Its focus is to grow the business with its existing international client base, expanding further into the Global arena with a stronger focus on key markets.
James Caan, Hamilton Bradshaw said on the investment: & lsquo;Life Sciences is an ever-growing industry not only represented by the larger Blue Chip clients in Biopharmaceuticals, Diagnostics and MedTech, but also the smaller businesses focusing on specialty pharma in Europe and the US. Thomas and his 3 partners demonstrate strong leadership with truly international experience. They have an international outlook and strong client base and I’m delighted to welcome them to the HB portfolio.’
Thomas Schleimer, Euromedica said on the investment:
& lsquo;With already 26 years in the Life Sciences search business this is a new milestone for Euromedica. For the first time we will be a partner led organisation with the management team having invested directly in this specialised business. We will continue to offer an excellent capability to attract top international executive leadership talent for our client base, whilst supporting our candidates throughout the hiring process. In a market where top talent is becoming more difficult to source and engage with, highly specialised search consultancies will be in even greater demand.’